Cisplatin-Teva, 1 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
7680479980701
CH-47998
Konzentrat
Associated product:
CISPLATIN Teva 100 mg/100ml flac 100 ml
1 / 3
google
Article details
- Package size
- 1 x 100mg/100ml
- Selling units
- 100
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.545 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 122.90
Specialties list
Yes
Generic
Yes
SL addition date:
01/11/2009
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 47998
- Drug name
- Cisplatin-Teva, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XA01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 09/10/1987
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- CISPLATIN Teva 100 mg/100ml flac 100 ml
- Description (DE)
- CISPLATIN Teva 100 mg/100ml Durchstf 100 ml
- Market launch
- 21/07/2009
- Market withdrawal
- 30/08/2025
- Narcotic (BTM)
- No